Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Soodaeva (Moscow, Russian Federation), . Klimanov (Moscow, Russian Federation), . Zaprudnova (Vladimir, Russian Federation), . Saed (Vladimir, Russian Federation), . Nikitina (Moscow, Russian Federation), . Novoselov (Vladimir, Russian Federation). The study of the activity of antioxidant enzymes in exhaled breath condensate (EBC) in patients with COPD. 606

Member's Comments

No comment yet.

Related content which might interest you: Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006 Detection and variability of cytokine-levels in exhaled breath condensate (EBC) of patients with stable COPD Source: Eur Respir J 2003; 22: Suppl. 45, 438s Year: 2003 Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 Influence of smoking on indicators of free-radical oxidation in a condensate in exhaled breath condensate (EBC) at healthy and patients with bronchial asthma (BA) Source: Annual Congress 2010 - Smoking related disorders Year: 2010 Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 N-acetylcysteine reduces 8-isoprostane levels in exhaled breath condensate and serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 13s Year: 2005 Changes of intermediate substrates of carbohydrate metabolism in exhaled breath condensate (EBC) during COPD development Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Determinants of variability in exhaled breath condensate (EBC) in children Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 Increased 8-isoprostane in the exhaled breath condensate of down patients Source: Eur Respir J 2004; 24: Suppl. 48, 556s Year: 2004 The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 The markers of free radical oxidation in exhaled breath condensate (EBC) during the long-term smoking Source: Annual Congress 2009 - Tobacco smoke and inflammatory and immune effects Year: 2009 8-isoprostane in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Nitrite concentration in exhaled breath condensate correlates with markers of lung overdistension in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Changes in the ratios of stable nitric oxide metabolites in the exhaled breath condensate in patients with COPD during antioxidant therapy. Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 The dynamics of free radical parameters in exhaled breath condensate (EBC) in smokers during the course of physical workload Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation Year: 2011 Protein pattern of exhaled breath condensate (EBC) and saliva Source: Eur Respir J 2001; 18: Suppl. 33, 461s Year: 2001